Cullinan Therapeutics Inc
(CGEM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,141 | 109,195 | 136,283 | 161,173 | -12,892 |
| Depreciation Amortization | 72 | 93 | 34 | 25 | 13 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -19,568 |
| Accounts payable and accrued liabilities | -630 | -509 | -1,654 | -70 | 3,137 |
| Other Working Capital | 1,180 | 11,176 | 16,187 | 51,101 | 3,028 |
| Other Operating Activity | 6,522 | -246,619 | -252,531 | -259,557 | 4,374 |
| Operating Cash Flow | $-50,997 | $-126,664 | $-101,681 | $-47,328 | $-21,908 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -159 | -1,042 | -251 | N/A | N/A |
| Net Acquisitions | N/A | 275,000 | 275,000 | 270,000 | N/A |
| Purchase Of Investment | -89,139 | -377,916 | -217,497 | -93,370 | -57,020 |
| Sale Of Investment | 104,482 | 352,933 | 220,333 | 158,933 | 91,731 |
| Investing Cash Flow | $15,184 | $248,975 | $277,585 | $335,563 | $34,711 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,825 | 2,375 | 2,200 | 2,200 | 800 |
| Common Stock Issued | -36 | 6,020 | 5,826 | 4,401 | 1,588 |
| Other Financing Activity | 0 | -34,328 | -1,047 | -1,047 | 1,153 |
| Financing Cash Flow | $1,789 | $-25,933 | $6,979 | $5,554 | $3,541 |
| Beginning Cash Position | 156,152 | 59,774 | 59,774 | 59,774 | 59,774 |
| End Cash Position | 122,128 | 156,152 | 242,657 | 353,563 | 76,118 |
| Net Cash Flow | $-34,024 | $96,378 | $182,883 | $293,789 | $16,344 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,997 | -126,664 | -101,681 | -47,328 | -21,908 |
| Capital Expenditure | -159 | -1,133 | -251 | 0 | 0 |
| Free Cash Flow | -51,156 | -127,797 | -101,932 | -47,328 | -21,908 |